Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A

BACKGROUND: Ovarian cancer (OC) is a gynecological malignancy with a high mortality. Cisplatin-based treatment is the typical treatment regimen for OC patients; however, it may cause unfavorable resistance. The current study intends to explore the function of cancer-associated fibroblast (CAF)-deriv...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Cell Int
Glavni autori: Guo, Hua, Ha, Chunfang, Dong, Hui, Yang, Zhijuan, Ma, Yuan, Ding, Yonghui
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Primary Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6925473/
https://ncbi.nlm.nih.gov/pubmed/31889899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-1051-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items